ArticleFrontiers in pharmacology2020

Low Level Antibodies Against Alpha-Tropomyosin Are Associated With Increased Risk of Coronary Heart Disease.

Yin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.